{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-3273", "FDA", "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments\u201d", "Nonrulemaking", "2026-04-15T13:05:22Z", "0b000064b9240b98"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-3273"], "units": {}, "query_ms": 0.37211994640529156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}